Company List
GlaxoSmithKline (GSK) Drug List1
| S.No. | Company Name | Short Description | No of Drugs | Company Drug Price | Action | |
|---|---|---|---|---|---|---|
| 1 | GlaxoSmithKline (GSK) | GlaxoSmithKline operates as a research-based pharmaceutical company. The Company develops, manufactures, and markets vaccines, prescription, and over-the-counter medicines, as well as health-related consumer products. GlaxoSmithKline provides products for infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer. | 5 | 60.00 | BUY | Your Query |
| S.No. | Updated On | Drug | Price in USD | Action | ||
|---|---|---|---|---|---|---|
| 1 | Apr, 2020 | Benlysta Drug Sales & Forecast GSK drug Benlysta is the world’s first and only biologic medicine specifically approved for adult and paediatric lupus to treat systemic lupus erythemat.... | 15.00 | READ | BUY | Your Query |
| 2 | Apr, 2020 | Bexsero Vaccine Sales & Forecast Since its launch in 2015, GSK Bexsero has become the industry-leading meningitis B vaccine. In the United States, where it is licensed for 10 to 25 year o.... | 15.00 | READ | BUY | Your Query |
| 3 | Apr, 2020 | Juluca Drug Sales & Forecast GSK received United States FDA approval for Juluca in 2017, a once-daily, single pill 2DR regimen for HIV. Juluca combines dolutegravir with rilpivirine (.... | 15.00 | READ | BUY | Your Query |
| 4 | Apr, 2020 | Shingrix Vaccine Sales & Forecast Shingrix marks a step change in the prevention of shingles, a painful and potentially serious illness. The vaccine addresses the age-related decline in im.... | 15.00 | READ | BUY | Your Query |
| 5 | Apr, 2020 | Zejula Drug Sales & Forecast Zejula, GlaxoSmithKline (GSK) oral PARP inhibitor, is approved in the United States and Europe for women with recurrent ovarian cancer. MNG Tracker report.... | 15.00 | READ | BUY | Your Query |
